GO:0033625 positive regulation of integrin activation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033625 (positive regulation of integrin activation) is a biological process that increases the frequency, rate, or extent of integrin activation, converting integrins from a low-affinity to a high-affinity ligand-binding state.
• Integrin activation is driven by inside-out signaling that triggers conformational changes in the integrin heterodimer, enabling binding to extracellular matrix ligands and counter-receptors [1, 6].
• Key molecular players include talin, kindlin, and the integrin cytoplasmic tails; their engagement is essential for integrin activation and downstream signaling [1, 6].
• Positive regulation of integrin activation is critical for cell adhesion, migration, immune cell function, and tissue morphogenesis, and its dysregulation contributes to cancer, inflammation, and developmental disorders [2, 3, 5, 7].
• Diverse integrin heterodimers, such as αVβ1, α5β1, α3β1, and α4β1, are subject to positive regulation, and their activation modulates pathways like FAK/PI3K/AKT and PYK2/STAT3 [2, 3, 5].
• CRISPR-based knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect the causal roles of genes that positively regulate integrin activation [2, 3, 4].
Description
Integrins are heterodimeric cell-surface adhesion receptors that mediate interactions between cells and the extracellular matrix (ECM) or other cells. The process of positive regulation of integrin activation (GO:0033625) encompasses any signaling event that increases the frequency, rate, or extent of the transition of integrins from a low-affinity to a high-affinity ligand-binding state. This activation is not merely a passive consequence of ligand binding but is actively controlled by intracellular signals, a phenomenon known as inside-out signaling [1, 6]. Understanding this process is fundamental to cell biology because integrin activation governs diverse functions including cell adhesion, migration, proliferation, differentiation, and survival. Dysregulated integrin activation is implicated in numerous pathological conditions, ranging from cancer progression and metastasis to inflammatory diseases and developmental anomalies [2, 3, 5, 7]. Therefore, researchers across immunology, cancer biology, and developmental biology require robust models to study the positive regulation of integrin activation. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a comprehensive overview of the mechanisms, key genes, disease relevance, and research methodologies associated with GO:0033625.
positive regulation of integrin activation At A Glance
| GO ID | GO:0033625 |
|---|---|
| GO term | positive regulation of integrin activation |
| Ontology | biological_process |
| Synonym | positive regulation of integrin complex activation |
| Major function | Enhances the transition of integrins to a high-affinity ligand-binding state, promoting cell adhesion, migration, and signaling [1, 6]. |
| Key regulators | Talin, kindlin, and integrin cytoplasmic tail-binding proteins [1, 6]. |
| Associated integrins | αVβ1, α5β1, α3β1, α4β1, and others [2, 3, 5]. |
| Disease relevance | Cancer progression, inflammation, and tissue morphogenesis defects [2, 3, 5, 7]. |
What Is GO:0033625?
Positive regulation of integrin activation (GO:0033625) is defined as any process that activates or increases the frequency, rate, or extent of integrin activation. In practical terms, it refers to the intracellular signaling pathways and molecular events that shift integrin heterodimers into a conformation with higher affinity for their extracellular ligands, thereby promoting adhesion and downstream signaling.
Why Is positive regulation of integrin activation Important in Cell Biology?
Positive regulation of integrin activation is a central control point in cell adhesion and signaling, influencing processes as diverse as immune surveillance, wound healing, and embryonic development [1, 5, 7]. Because integrins are not constitutively active, their regulated activation allows cells to dynamically respond to environmental cues. Disruption of this regulation can lead to pathological states: excessive integrin activation promotes cancer cell invasion and metastasis [2, 3], while defective activation contributes to immune deficiencies and developmental abnormalities [4, 7]. Thus, understanding the positive regulation of integrin activation is essential for both basic biology and therapeutic development.
• Controls cell adhesion and migration, which are fundamental for tissue organization and repair.
• Regulates immune cell trafficking and activation, including neutrophil infiltration and dendritic cell function [4, 5].
• Drives cancer progression by promoting ECM remodeling, invasion, and metastasis [2, 3].
• Modulates intracellular signaling pathways such as FAK/PI3K/AKT and PYK2/STAT3 [2, 3].
• Essential for tissue morphogenesis, as shown in Drosophila contractile wave studies.
• Involved in lymphocyte-fibroblast interactions that shape immune responses.
• Provides a target for therapeutic intervention in inflammatory diseases and cancer [1, 3].
• Serves as a paradigm for studying inside-out signaling and mechanotransduction [1, 7].
What Happens During positive regulation of integrin activation?
Initiation by intracellular signals
In simple terms: A signal inside the cell tells the integrin to change shape so it can grab onto things outside.
Positive regulation of integrin activation begins with intracellular signaling events, often triggered by chemokines, growth factors, or mechanical forces. These signals converge on the integrin cytoplasmic tails, particularly the β-subunit tail, and recruit adaptor proteins such as talin and kindlin. This recruitment disrupts a salt bridge between the α and β tails, leading to conformational changes that propagate to the extracellular domain [1, 6].
Conformational change and affinity switch
In simple terms: The integrin flips from a bent, low-affinity shape to an extended, high-affinity shape.
The binding of talin and kindlin to the β-integrin tail induces a switch from a bent, low-affinity conformation to an extended, high-affinity conformation. This allosteric change exposes the ligand-binding pocket, allowing the integrin to bind ECM proteins or counter-receptors with high affinity [1, 6]. This step is the hallmark of integrin activation and is tightly regulated to avoid inappropriate adhesion.
Ligand binding and clustering
In simple terms: Once activated, integrins grab onto their targets and group together to send stronger signals.
Upon activation, integrins bind to their ligands, such as fibronectin, collagen, or VCAM-1. Ligand binding promotes integrin clustering, which strengthens adhesion and initiates downstream signaling cascades, including FAK, Src, and PI3K/AKT pathways [2, 3]. Clustering also reinforces the active conformation, creating a positive feedback loop.
Downstream signaling and cellular responses
In simple terms: The activated integrins send messages inside the cell that change its behavior.
Activated integrins trigger intracellular signaling that regulates cell survival, proliferation, migration, and gene expression. For example, integrin αVβ1-activated PYK2 promotes NSCLC progression via the STAT3-VGF axis, and ITGA5-induced FAK/PI3K/AKT activation drives TNBC progression. These pathways underscore the importance of positive regulation of integrin activation in disease [2, 3].
Termination and recycling
In simple terms: The cell can turn off the signal and recycle the integrins when needed.
Positive regulation is balanced by negative regulatory mechanisms that return integrins to an inactive state, often through phosphorylation, ubiquitination, or endocytosis. This dynamic cycling allows cells to rapidly modulate adhesion in response to changing environments [1, 6]. Dysregulation of termination can lead to persistent adhesion and pathological states.
Key Genes Involved in GO:0033625 positive regulation of integrin activation
The following genes and proteins are central to the positive regulation of integrin activation, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGB1 | Integrin β1 subunit; forms heterodimers with various α subunits and is a target of talin/kindlin-mediated activation [1, 6]. | Knockout and point mutations reveal its role in adhesion and signaling. |
| ITGA5 | Integrin α5 subunit; partners with β1 to form fibronectin receptor; its activation promotes FAK/PI3K/AKT signaling. | Overexpression and knockout models in TNBC. |
| ITGAV | Integrin αV subunit; forms αVβ1 with β1; activation drives PYK2/STAT3 signaling in NSCLC. | Knockdown and knock-in studies in lung cancer. |
| ITGA3 | Integrin α3 subunit; forms α3β1; regulates neutrophil infiltration. | Conditional knockout in immune cells. |
| ITGA4 | Integrin α4 subunit; forms α4β1; mediates lymphocyte-fibroblast interactions. | Blocking antibodies and knockout models. |
| TLN1 | Talin-1; directly binds β-integrin tails to trigger activation [1, 6]. | Knockout and point mutations to dissect activation mechanism. |
| FERMT2 | Kindlin-2; co-activates integrins by binding β-tails. | Knockout and overexpression studies. |
| PTK2 | FAK; downstream effector of activated integrins, promotes survival and migration. | Inhibitors and knockout models. |
| PTK2B | PYK2; activated by integrin αVβ1 and drives STAT3-VGF axis. | Knockdown and overexpression in NSCLC. |
| JAK2 | JAK2-V617F mutation upregulates pro-inflammatory cytokines via integrin signaling. | Knock-in of JAK2-V617F in hematopoietic cells. |
| STAT3 | Transcription factor activated downstream of integrin signaling. | Knockout and reporter assays. |
| PIK3CA | PI3K catalytic subunit; mediates integrin-induced AKT activation. | Overexpression and knockout. |
| AKT1 | Serine/threonine kinase; downstream of PI3K in integrin signaling. | Phospho-AKT assays and knockout. |
| CD163 | Marker on a dendritic cell subset with distinct integrin activation profiles. | Flow cytometry and functional assays. |
| ZNF460 | Transcription factor that promotes circRPPH1 expression, indirectly enhancing ITGA5-mediated integrin activation. | Knockdown and overexpression. |
| VGF | Neurotrophic factor induced by STAT3 downstream of integrin αVβ1. | Knockdown and overexpression in NSCLC. |
How Is positive regulation of integrin activation Regulated?
Positive regulation of integrin activation is itself tightly regulated by multiple mechanisms. Inside-out signaling initiated by chemokine or growth factor receptors leads to the recruitment of talin and kindlin to integrin tails, a process controlled by kinases such as PKC and Rap1 [1, 6]. Mechanical forces can also directly modulate integrin affinity, as observed during Drosophila tissue morphogenesis. Additionally, the JAK2-V617F mutation in hematopoietic cells upregulates pro-inflammatory cytokines via integrin signaling, indicating a link between cytokine signaling and integrin activation. Negative regulators, including phosphatases and endocytic recycling pathways, ensure that activation is transient and spatially confined.
positive regulation of integrin activation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGA5 | Triple-negative breast cancer progression | Knockout and overexpression in TNBC cell lines |
| ITGAV | Non-small-cell lung cancer progression | Knockdown and knock-in in NSCLC cells |
| JAK2 | Myeloproliferative neoplasms and inflammation | JAK2-V617F knock-in hematopoietic cells |
| ITGA3 | Neutrophil infiltration in inflammation | Conditional knockout in mouse neutrophils |
| ITGB1 | Anoikis resistance and cancer survival | Knockout and point mutations in cancer cells |
Cancer progression and metastasis
Positive regulation of integrin activation is frequently hijacked in cancer. In triple-negative breast cancer, ZNF460-mediated circRPPH1 promotes ITGA5-induced FAK/PI3K/AKT activation, driving tumor progression. In non-small-cell lung cancer, integrin αVβ1-activated PYK2 promotes progression via the STAT3-VGF axis. These findings highlight integrin activation as a therapeutic target and a biomarker of aggressive disease [2, 3].
Inflammation and immune disorders
Integrin activation is critical for immune cell trafficking and function. In JAK2-V617F positive hematopoietic cells, activation of integrin signaling up-regulates pro-inflammatory cytokines, linking integrin activation to myeloproliferative neoplasms and inflammation. Neutrophil infiltration is regulated by integrin α3β1 and other factors, underscoring the role of integrin activation in inflammatory responses. Dendritic cell subsets with distinct integrin activation profiles prime CD8+ T cells, affecting adaptive immunity.
Developmental and tissue morphogenesis defects
Integrin activation is essential for tissue morphogenesis. Mechanical regulation of substrate adhesion and de-adhesion drives a cell-contractile wave during Drosophila tissue morphogenesis, a process dependent on regulated integrin activation. Disruption of these mechanisms can lead to developmental abnormalities.
Anoikis and cell survival
Integrin-mediated adhesion provides survival signals; loss of attachment leads to anoikis, a form of apoptosis. Positive regulation of integrin activation can suppress anoikis, contributing to cancer cell survival and metastasis.
From positive regulation of integrin activation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ITGA5 positively regulate integrin activation in TNBC? | ITGA5 knockout and overexpression in TNBC cell lines |
| What is the role of ITGAV in NSCLC progression? | ITGAV knockdown and knock-in in NSCLC cells |
| How does JAK2-V617F affect integrin signaling? | JAK2-V617F knock-in hematopoietic cells |
| Does ITGA3 regulate neutrophil infiltration? | Conditional ITGA3 knockout in mouse neutrophils |
| What is the impact of talin-1 on integrin activation? | TLN1 knockout and point mutations |
| How does mechanical force regulate integrin activation? | Drosophila tissue morphogenesis models |
How to Study the positive regulation of integrin activation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with activation-specific antibodies | Integrin activation state | Immune cell profiling |
| Cell adhesion assay | Binding to ECM ligands | Functional validation of integrin activation |
| Immunoblotting for phospho-FAK/PYK2/AKT | Downstream signaling activation | Cancer cell signaling [2, 3] |
| Live-cell imaging | Integrin conformational dynamics | Mechanotransduction studies |
| Traction force microscopy | Mechanical forces during adhesion | Drosophila morphogenesis |
| CRISPR knockout library screening | Identification of positive regulators | Cancer dependency screens [2, 3] |
| RNA-seq | Transcriptional changes upon integrin activation | Pathway analysis [1, 2] |
| Proximity ligation assay | Protein-protein interactions (e.g., talin-integrin) | Mechanism studies |
Flow cytometry and adhesion assays
Flow cytometry can measure integrin activation using conformation-specific antibodies or ligand mimetics. Adhesion assays quantify cell binding to ECM proteins, providing functional readouts of positive regulation [4, 5].
Phospho-proteomics and signaling analysis
Phospho-proteomics and immunoblotting for phosphorylated FAK, PYK2, AKT, and STAT3 reveal downstream signaling events triggered by integrin activation [2, 3].
Live-cell imaging and mechanobiology
Live-cell imaging of fluorescently tagged integrins or talin allows visualization of conformational changes and clustering in real time. Traction force microscopy measures mechanical forces exerted during adhesion and de-adhesion.
Genetic screens and CRISPR libraries
CRISPR knockout libraries can identify genes that positively regulate integrin activation. Bioinformatics analysis of screen data pinpoints enriched pathways and candidate regulators [2, 3].
How CRISPR Can Be Used to Study GO:0033625 positive regulation of integrin activation
Knockout
CRISPR knockout of genes such as ITGA5, ITGAV, or TLN1 can abolish positive regulation of integrin activation, revealing their necessity. For example, ITGA5 knockout reduces FAK/PI3K/AKT signaling in TNBC cells.
Point Mutation
Point mutations in integrin cytoplasmic tails or talin-binding sites can disrupt activation without affecting expression. Such models help dissect the precise molecular interactions required for positive regulation.
Knock-in
Knock-in of disease-associated mutations, such as JAK2-V617F, allows study of how mutant proteins drive integrin activation and downstream cytokine production in a physiological context.
Overexpression
Overexpression of integrins or their activators (e.g., ITGA5, ITGAV) can enhance integrin activation and promote oncogenic signaling, providing gain-of-function models for cancer research [2, 3].
How EDITGENE Supports positive regulation of integrin activation Research
Researchers studying positive regulation of integrin activation-related genes often need to determine whether a candidate gene is causally involved in the activation process or is merely a bystander. This requires precise genetic manipulation, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of integrin activation research.
Frequently Asked Questions About positive regulation of integrin activation
What is positive regulation of integrin activation?
Positive regulation of integrin activation (GO:0033625) is any process that increases the frequency, rate, or extent of integrin activation, shifting integrins to a high-affinity ligand-binding state.
What genes are involved in positive regulation of integrin activation?
Key genes include ITGB1, ITGA5, ITGAV, ITGA3, ITGA4, TLN1, FERMT2, PTK2, PTK2B, and JAK2, among others [1, 2, 3, 5, 8].
How does integrin activation occur?
Integrin activation occurs via inside-out signaling where talin and kindlin bind integrin tails, inducing conformational changes that increase ligand affinity [1, 6].
What diseases are associated with dysregulated integrin activation?
Dysregulated integrin activation is linked to cancer progression, inflammation, myeloproliferative neoplasms, and developmental defects [1, 2, 3, 5, 7].
What research methods are used to study positive regulation of integrin activation?
Common methods include flow cytometry, adhesion assays, phospho-proteomics, live-cell imaging, and CRISPR screens [2, 3, 4, 7].
Can CRISPR be used to study integrin activation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect the roles of genes in integrin activation [1, 2, 3].
What is the role of talin in integrin activation?
Talin binds to β-integrin cytoplasmic tails and is essential for triggering the conformational change that activates integrins [1, 6].
How is integrin activation regulated in immune cells?
In immune cells, integrin activation is regulated by chemokine signaling and is crucial for trafficking, as seen in neutrophils and dendritic cells [4, 5].
What is inside-out signaling in integrin activation?
Inside-out signaling refers to intracellular signals that induce conformational changes in integrins, enabling them to bind extracellular ligands with high affinity [1, 6].
Why is positive regulation of integrin activation important in cancer?
In cancer, positive regulation of integrin activation promotes cell survival, migration, and metastasis through pathways like FAK/PI3K/AKT and PYK2/STAT3 [2, 3].
Conclusion
Positive regulation of integrin activation (GO:0033625) is a fundamental biological process that controls cell adhesion, migration, and signaling. Its dysregulation contributes to cancer, inflammation, and developmental disorders, making it a critical area of research. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new regulators and therapeutic targets. EDITGENE provides comprehensive services to support these efforts, from custom knockout and knock-in cell lines to library screening and bioinformatics.
References
- 1. Baldauf CK et al.. 2025. Activation of integrin signaling up-regulates pro-inflammatory cytokines in JAK2-V617F positive hematopoietic cells.. Cell Commun Signal 23(1):368 PMID: 40790213
- 2. Zhang C et al.. 2024. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.. Mol Cancer 23(1):33 PMID: 38355583
- 3. Wu Z et al.. 2024. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.. Cell Commun Signal 22(1):313 PMID: 38844957
- 4. Bourdely P et al.. 2020. Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells.. Immunity 53(2):335-352.e8 PMID: 32610077
- 5. Subramanian P et al.. 2016. Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors.. Curr Opin Hematol 23(1):36-43 PMID: 26554893
- 6. Frisch SM et al.. 1997. Integrins and anoikis.. Curr Opin Cell Biol 9(5):701-6 PMID: 9330874
- 7. Collinet C et al.. 2024. Mechanical regulation of substrate adhesion and de-adhesion drives a cell-contractile wave during Drosophila tissue morphogenesis.. Dev Cell 59(1):156-172.e7 PMID: 38103554
- 8. Murakami S et al.. 1997. Lymphocyte-fibroblast interactions.. Crit Rev Oral Biol Med 8(1):40-50 PMID: 9063624
